Related Experiment Videos
Menopause: refining benefits and risks of hormone replacement therapy
1Menopause Clinic, King's College Hospital, London, UK.
Current Opinion in Obstetrics & Gynecology
|June 1, 1995
Summary
Hormone replacement therapy (HRT) shows protective effects against osteoporosis and arterial disease. Recent data refine understanding of HRT benefits and risks, including breast cancer concerns.
Area of Science:
- Reproductive Endocrinology
- Cardiovascular Health
- Bone Metabolism
Background:
- Understanding of menopause and hormone replacement therapy (HRT) evolved between 1993-1994.
- Published data during this period refined the assessment of HRT's benefits and risks.
Purpose of the Study:
- To present evidence on HRT's protective effects against osteoporosis and arterial disease.
- To discuss evolving perspectives on progestogen use, bleeding patterns, and endometrial status in HRT.
- To review controversies regarding HRT and breast cancer risk.
Main Methods:
- Review of scientific literature published in 1993-1994.
- Analysis of data on gonadal hormone effects on the vessel wall.
- Examination of clinical attitudes and controversies surrounding HRT.
Main Results:
- Further evidence supports HRT's role in preventing osteoporosis and arterial disease.
- Direct effects of gonadal hormones on blood vessels were highlighted.
- Shifting attitudes towards progestogen addition, withdrawal bleeding, and endometrial status were observed.
- Controversies linking HRT to breast cancer risk were reviewed.
Conclusions:
- HRT offers protective benefits for bone health and cardiovascular health.
- Ongoing research and data analysis continue to refine the understanding of HRT's complex risk-benefit profile.
- New delivery methods for estradiol are emerging.